Achilles Therapeutics PLC at Eqt Life Sciences BioCapital Europe Transcript
(audio in progress) in the life sciences, health and technology sectors. So the first speaker that I've got the pleasure of introducing is Dr. Iraj Ali, CEO at Achilles Therapeutics. So Achilles is a Nasdaq-listed biotechnology company developing novel cancer immunotherapies. Iraj has been the CEO since 2018 and previously was a managing partner at Syncona. So [to give a quick] -- I'll hand it over to you.
Thanks, Kate. Okay, so it looks like it's working. So thank you, everybody. Delighted to have this opportunity to tell you a little bit more about Achilles Therapeutics. This presentation is available on our website, and I urge people to read the forward-looking statements and disclaimers.
So we are a solid tumor cancer company, developing transformative medicines using precision cell therapy, which is a big mouthful to say we think that we have got a novel and breakthrough approach into treating the solid tumors. The company has two active clinical programs and substantial operations with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
